Polymer–drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (1), 132-143
- https://doi.org/10.1002/jps.10533
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Synthesis of novel amphiphilic star-shaped poly(ɛ-caprolactone)-block-poly(N-(2-hydroxypropyl)methacrylamide) by combination of ring-opening and chain transfer polymerizationPolymer, 2002
- The study of hydrogen bonding and miscibility in poly(vinylpyridines) with phenolic resinPolymer, 2002
- Complexation of Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) Micelles with Multifunctional Carboxylic AcidsMacromolecules, 2001
- Miscibility and phase structure of binary blends of poly(L‐lactide) and poly(vinyl alcohol)Journal of Applied Polymer Science, 2001
- The use of solubility parameters in pharmaceutical dosage form designInternational Journal of Pharmaceutics, 1997
- Expanded solubility parameter treatment for classification and use of chromatographic solvents and adsorbentsAnalytical Chemistry, 1978
- Ellipticine derivativesJournal of Medicinal Chemistry, 1975
- A method for estimating both the solubility parameters and molar volumes of liquidsPolymer Engineering & Science, 1974
- Studies on amylose and its derivatives. Part VI. Estimation of cohesive energy densities of some amylose derivativesBiopolymers, 1965
- Alkaloids of Ochrosia elliptica Labill.1Journal of the American Chemical Society, 1959